Lipidio Pharmaceuticals
PrivateLast Round
Series A
Extension
Nov 10, 2022
Total Funding Raised
$20M
Company Overview
Lipidio Pharmaceuticals operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A Extension round in November 2022.
Lipidio Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for dermatological and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lipidio Pharmaceuticals Comparables
Compare Lipidio Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galderma | 61% | |
| Kintor Pharmaceutical Ltd | 55% | |
| Sagimet Biosciences | 52% |
For institutional investors. Book with your work email.
Lipidio Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 10, 2022 | ||||
| Series A | Mar 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lipidio Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Series A |
| Alethea Capital Management, LLC | Series A Extension, Series A |
| Bencao Capital | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 102% MoM, reaching 1.5K.
- Apr 20, 2026
Monthly visitors grew 341% MoM.
For institutional investors. Book with your work email.
Lipidio Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lipidio Pharmaceuticals's valuation, stock price, and market status.
Is Lipidio Pharmaceuticals a public or private company?
Lipidio Pharmaceuticals is a private company.
What is the current stock price of Lipidio Pharmaceuticals?
Lipidio Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Lipidio Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lipidio Pharmaceuticals worth (valuation)?
Valuation information for Lipidio Pharmaceuticals is not publicly available.
Can I buy Lipidio Pharmaceuticals stock?
Lipidio Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lipidio Pharmaceuticals's last funding round?
Lipidio Pharmaceuticals's most recent funding round was Series A Extension on November 10, 2022.
Who are the main investors in Lipidio Pharmaceuticals?
Key investors in Lipidio Pharmaceuticals include Foundation for Prader-Willi Research, Alethea Capital Management, LLC, Bencao Capital.
Will Lipidio Pharmaceuticals IPO soon?
No public IPO plans have been announced for Lipidio Pharmaceuticals.
How can I track Lipidio Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Lipidio Pharmaceuticals's shares on secondary markets.